Latest News in the pharma Industry

All

Catalent Supply Services To Open New Clinical Supply Facility In San Diego

Catalent Supply Services To Open New Clinical Supply Facility In San Diego

3 Oct 2020

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced it is to invest $9 million in a new clinical supply fa...

Read more 
Catalent Supports Rapid Development and Supply of Nocion Therapeutics’ Clinical Trial Materials for Acute and Chronic Cough Using Blow-Fill-Seal Technology

Catalent Supports Rapid Development and Supply of Nocion Therapeutics’ Clinical Trial Materials for Acute and Chronic Cough Using Blow-Fill-Seal Technology

3 Oct 2020

Catalent today welcomed the news from Nocion Therapeutics, Inc., a biopharmaceutical company developing novel small molecule charged sodium channel blockers, that its first patient has been dosed with NOC-100, an inhaled formula of its NTX-1175 small m...

Read more 
Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland

Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland

3 Oct 2020

Catalent today announced that it is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its gene therapy campus in Harmans, Maryland.

Read more 
SGD Pharma extends industry-leading RTU molded glass vial range

SGD Pharma extends industry-leading RTU molded glass vial range

2 Oct 2020

SGD Pharma has expanded its ready-to-use (RTU) molded glass vial range to introduce a market-first 50ml volume option in tray developed at introduce a market-first 50ml volume option in tray developed at industrial scale by a molded glass manufact...

Read more 
Why ISO 17034?

Why ISO 17034?

2 Oct 2020

As a provider of reference materials for a broad range of scientific industries, many of LGC Standards’ products are manufactured according to the International Organisation for Standardisation’s accreditation scheme for reference material providers...

Read more 
Discover our virtual booth!

Discover our virtual booth!

2 Oct 2020

Nemera is at the forefront of this transformation. We are convinced it is the best way to move forward and continue to serve customers and patients. Discover our digital booth, live the experience and join us on our journey.

Read more 
Quay Pharmaceuticals Expands in America

Quay Pharmaceuticals Expands in America

2 Oct 2020

Quay Pharma has underlined its position as a major player in the global pharmaceutical contract development and manufacturing (CDMO) sector with the creation of a US subsidiary.

Read more 
Chem Flowtronics Announcements

Chem Flowtronics Announcements

2 Oct 2020

9/10/2020  - Bantec Sanitizing has engaged Chem Flowtronics to produce sanitizer blending machines for national distribution.

2/18/2019 - Chem Flowtronics signs agreement with Novartis providing exclusive manufacturing rights for a propriet...

Read more 
ZIM Announces Submission of Marketing Authorization Application for 'Rizatriptan' orally dissolving film in Europe

ZIM Announces Submission of Marketing Authorization Application for 'Rizatriptan' orally dissolving film in Europe

1 Oct 2020

ZIM Laboratories Limited (ZIM) announced that it has filed the regulatory dossier for approval of Rizatriptan orally dissolving film in Europe.Rizatriptan orally dissolving film is a product developed using our Thinoral® technology which yields instant...

Read more 
BIAL and Recipharm expand long-term supply agreement for opicapone API

BIAL and Recipharm expand long-term supply agreement for opicapone API

1 Oct 2020

Portuguese pharma company, BIAL, and global contract development and manufacturing organisation (CDMO), Recipharm, have expanded a long-term agreement for the global manufacturing and supply of BIAL’s proprietary molecule opicapone.

Read more 
Xellia Pharmaceuticals demonstrates commitment to the fight against sepsis

Xellia Pharmaceuticals demonstrates commitment to the fight against sepsis

1 Oct 2020

Copenhagen, Denmark, 29 September 2020 - Xellia Pharmaceuticals (‘Xellia’), a specialty pharmaceutical company focusing on providing important anti-infective treatments against serious and often life-threatening infections, announces support for Sepsis...

Read more 
Cleveland, Ohio, passes FDA inspection of Injectable Drug Manufacturing Methods, Facilities, Processes & Controls

Cleveland, Ohio, passes FDA inspection of Injectable Drug Manufacturing Methods, Facilities, Processes & Controls

1 Oct 2020

Cleveland site to manufacture Xellia's aseptic injectables for the US market

Copenhagen, Denmark, 26 March 2020 - Xellia Pharmaceuticals (‘Xellia’), a specialty pharmaceutical company focusing on providing important anti-infective treatments a...

Read more